Aditxt Boosts Convertible Note Financing to $6.25M, Sells Notes at 35% Discount
ADTX has more than doubled off its 52-week low of $0.004 on elevated volume (14× avg).
Summary
Aditxt has increased its senior secured convertible note financing to $6.25 million and sold an additional $0.77 million in principal amount of notes for $0.5 million in cash, representing a significant discount. This substantial financing is secured by assets of its subsidiary, Ignite Proteomics. The company continues to face severe financial distress, as evidenced by a recent Nasdaq delisting notice, a 1-for-27 reverse stock split, and previous disclosures of substantial doubt about its ability to continue as a going concern. This highly dilutive and costly capital raise underscores the company's urgent need for liquidity.
At the time of this announcement, ADTX was trading at $0.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7K. The 52-week trading range was $0.00 to $53,450.61. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.